Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study

ConclusionsSulfonylureas were associated with the highest rates of serious hypoglycemia. Among all study drugs, the highest rate was seen with glyburide. Pioglitazone was associated with a lower adjusted hazard for serious hypoglycemia vs metformin, while rosiglitazone and nateglinide had hazards similar to that of metformin.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fpds.4337

Source: Pharmacoepidemiology and Drug Safety - November 6, 2017 Category: Drugs & Pharmacology Authors: Charles E. Leonard, Xu Han, Colleen M. Brensinger, Warren B. Bilker, Serena Cardillo, James H. Flory, Sean Hennessy Tags: ORIGINAL REPORT Source Type: research